Selected Funding Opportunities
Request for Applications (RFAs)
| Title | Activity Code | Announcement Number | Participating Organization | Application Due Dates |
| Fall 2018 Developmental Grant Program | CFAR | 10/01/2018 | ||
| Improving Implementation of Seek, Test, Treat & Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01 Clinical Trial Required) | R01 | NIDA | 11/15/2018 | |
| Tobacco Regulatory Science | R01 | NIAAA, NIDA, NHLBI
|
2/13/2019
|
|
|
R21 |
||||
| Tobacco Regulatory Science Small Grant Program for New Investigators | R03 | |||
| NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (Clinical Trial Option) | DP1 | NIDA | 8/14/2018, 8/14/2019, 8/14/2020 | |
| Advancing Exceptional Research on HIV/AIDS and Substance Abuse | R01 | NIDA | 8/22/2018; 8/22/2019; |
Program Announcements (PAs)
| Title | Activity Code | Announcement Number | Participating Organization | Application Due Dates |
| Emerging Global Leader Award | K43 | PAR-17-001 | FIC, NIMH, ORWH | 11/7/2018 |
| Tobacco Use and HIV in Low and Middle Income Countries (Clinical Trial Optional) | R01 |
PAR-18-023 | NIDA, NCI | 1/7/2019, 5/7/2019, 1/7/2020; 5/7/2019, 1/7/2020, 5/7/2020, 1/7/2021, 5/7/2021, 1/7/2022 |
| R21 | PAR-18-022 | |||
| Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir | R01 | PAR-16-115 | NIAID | 1/9/2019 |
| International Research Scientist Development Award (IRSDA) | K01 | PAR-17-002 | FIC, NCI | 3/7/2019 |
| A Family-Centered Self-Management of Chronic Conditions | R01 | PA-18-383 | NINR | Standard dates |
| AIDS-Science Track Award for Research Transition | R03 | PA-15-290 | NIDA | Standard AIDS dates |
| Alcohol Research Resource Awards | R24 | PAR-17-170 | NIAAA | Standard dates |
| HIV-1 infection of the Central Nervous System | R01 | PA-17-100 | NIAAA, NIDA | Standard AIDS dates |
| HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research | R21 | PA-17-278 | NIAID, NCI, NIAAA | Standard AIDS dates |
| R01 | PA -17-279 | |||
| In Vitro and Animal Model Studies on HBV/HIV Co-Infection | R01 | PA-17-280 | NIAID, NCI, NIAAA | Standard AIDS dates |
| R21 | PA-17-281 | |||
| Wearable Alcohol Biosensors (STTR) | R41/R42 | PA-18-785 | NIAAA | Standard dates |
| Wearable Alcohol Biosensors (SBIR) | R43/R44 | PA-18-786 | NIAAA | Standard dates |
| NIAID Career Transition Award | K22 | PAR-16-434 | NIAID | Standard dates |
| Secondary Analyses of Alcohol and Chronic Disease | R03 | PA-16-394 | NIAAA, NCI | Standard dates |
| R01 | PA-16-395 | |||
| Strategies for the Improvement of HIV Envelope Protein Expression and Yield | R41/R42 | PA-16-182 | NIAID | Standard AIDS dates |
| R43/R44 | PA-16-184 | |||
| Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics | R21 | PA-17-282 | NIAID | Standard dates |
| R01 | PA-17-283 | |||
| Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder | R21 | PA-18-620 | NIAAA | Standard dates |
| R01 | PA-18-619 | |||
| Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence | R01 | PA-18-603 | NIAAA, NIDA | Standard dates |
| R03 | PA-18-601 | |||
| R21 | PA-18-602 |
